DIVERSA

At DIVERSA we specialize in pharmaceutical technology and #drugdelivery solutions using our lipid nanoemulsions. Today we are starting our participation #bioeuropespring and look forward to connecting with many prospective partners. Let's start the therapeutic revolution. Thanks to Scienseed for this beautiful animation video.

Lipid nanoparticles hold great promise but face significant development challenges. From stability issues to targeting efficiency, these hurdles impact their clinical success. DIVERSA's R+D effort is committed to overcoming these challenges with innovative solutions. 🚀 Check out our latest blog to discover how DIVERSA’s lipid-based nanosystems are overcoming key obstacles to the therapeutic success of nanomedicines. 👇🏼 https://lnkd.in/gy_xySXz #drugdelivery #nanoparticle #deliveryvehicles #nanotechnology #nanomedicine

🟡 Lipid nanoparticles have shown incredible results in clinical practice and are revolutionizing nanomedicine. However, their development still faces numerous challenges in expanding their use to additional medical applications. At DIVERSA, we develop innovative solutions to overcome these challenges, working towards enhancing the effectiveness and applicability of lipid-based nanosystems to cover unmet clinical needs. Want to learn how we do it? 📩 Subscribe to our monthly newsletter! Every month, get exclusive scientific content, insights on current challenges, and the latest discoveries in nanotechnology. 👉🏽 Subscribe now to receive the next issue in your inbox: bit.ly/subs_newsletter #drugdelivery #nanotechnology #nanoparticles #nanomedicine #biotechnology

💥 The rapid advancement of gene therapy continues to transform medicine, with mRNA-based treatments at the forefront. Among the latest breakthroughs is Moderna's mRESVIA, mRNA vaccine approved by the FDA for respiratory syncytial virus (RSV). RSV is a seasonal respiratory virus that can cause severe infections, particularly in infants and older adults. This approval highlights the growing impact of mRNA technology in the development of new therapies and vaccines. From infectious diseases to personalized medicine, mRNA therapy is driving the next generation of treatments. At DIVERSA, we are committed to advancing mRNA delivery technology. Therefore, our DIVERSA mRNA Delivery Nanoparticles offers a simple and efficient method for mRNA delivery, rendering comparable results to lipid nanoparticles approved for clinical use. Explore DIVERSA mRNA Delivery Nanoparticles on our website (insert link) and reach out for more information or support 💻 #mRNAvaccine #RNAdelivery #innovation #RSV #lipidnanoparticles #nanotechnology 

📢 We are thrilled to announce that we have been awarded two grants from Consellería de Emprego, Comercio e Emigración- Investigo Program! This initiative supports the employment of young people under 30 in research and innovation projects. These grants will enable us to further our research and innovation efforts, contributing to impactful advancements. We are excited to introduce our new team members: Irene Morín Jiménez: has a Biology degree from USC. She has experience as a lab technician, focusing her professional career in nanoformulation, especially lipid nanosystems, for the encapsulation of drugs and nucleic acids for therapeutic purposes. Paula Martínez Cagigas: has a Biotechnology degree from USC. She focusses her professional career on research related to the development of nanosystems for their application in gene delivery. Additionally, she has a master’s degree in advanced biotechnology, allowing her to become familiar with the business side of the biotech industry. 🙏 Thank you to the Investigo Program for this incredible opportunity, and to Consellería de Emprego, Comercio e Emigración, Secretaría Xeral de Emprego e Relacións Laborais, Subdirección Xeral de Emprego and Servizo de Emprego por Conta Allea 💼 #Research #Innovation #YouthEmployment #InvestigoProgram

Gene therapy is revolutionizing modern medicine, and the choice of delivery vector is crucial for success. Non-viral vectors, such as lipid nanoparticles, offer several significant advantages over adeno-associated viruses (AAVs):   🌟 LNPs vs. AAVs: - Cost-Effective: DIVERSA LNPs are easier and cheaper to produce, eliminating the need for complex instrumentation. - Higher Capacity: LNPs can carry larger genetic payloads, accommodating RNAs, DNAs, and proteins. - Enhanced Safety: LNPs reduce the risk of immunogenic and oncogenic effects, avoiding liver toxicity. - Targeted Delivery: LNPs can be tailored to target specific tissues and organs through surface decoration with ligands or proteins. - Precise Tracking: At DIVERSA, we offer fluorescent options for LNPs, allowing for easy tracking and control within cells and organs. 🚀 DIVERSA is committed to virus-free technologies, believing in LNPs as a safe, affordable, and tunable alternative to viral vectors. #GeneTherapy #AdenoAssociatedViruses #LipidNanoparticles #Biotechnology #Innovation #Health #Nanotechnology

🚀 At DIVERSA, we contribute to the training of people, investing in the enrichment of their professional careers, especially with our innovative technology. We want to introduce you to the talented people who have been and continue to be part of DIVERSA TECHNOLOGIES: - Laura Taina-González is finishing her industrial PhD. Her time at DIVERSA has been crucial in focusing her career on the field of gene therapy formulations, developing several projects in collaboration with significant groups worldwide. - Marcelina Abal Sanisidro carried out an industrial PhD stay at our facilities. During her time at DIVERSA, she not only applied our technology to her research, but also had the opportunity to learn about the internal work of a biotech company. - Mónica Escobar García-Caro completed her master's internship with us. At DIVERSA she had her first contact with nanotechnology, participating in several interesting projects that allowed her to understand and learn about our technology. ✨ We are proud to contribute to the professional growth of such brilliant and passionate people. At DIVERSA, we continue to invest in talent and innovation ✨ #DIVERSA #Nanotechnology #Innovation #ProfessionalDevelopment #TechCareers #Training

The sixth edition of the #PELAwards (Plan de Emprego Local) was celebrated last July by Deputación da Coruña. PEL continues to highlight and reward transformative business initiatives that contribute significantly to the socioeconomic development of Galicia and the province of A Coruña. As a winner of the previous edition, we recognized the great value of this award as it has greatly propelled our ability to innovate and collaborate, strongly contributing to the development of DIVERSA and to accomplish our mission, improving people's health by the use of nanotechnology. We want to congratulate the winners of this year's edition! Pilgrim , Bico de Xeado, Insertega Reciclaje Textil, and TEMPO TRAINING - SOCIAL. For more information, visit the official PEL Awards page (https://www.pel.gal/premio) and check out the article on La Voz de Galicia  (https://lnkd.in/d2u4_wFu). #PELawards #Innovation #LocalEmploymentPlan #LocalBusiness Video owned by Deputación da Coruña

🎉 Introducing DIVERSA Technologies's new mRNA delivery nanoparticles! Boost your research with these cutting-edge nanoparticles designed for efficient and precise mRNA delivery. Discover these products with a special offer, a 20% discount.  Experience the power of a unique technology with exceptional benefits: ✔ User Friendly & Efficient ✔ Effective & Biocompatible ✔ Quick & Effective Delivery ✔ Traceability & Customization ➡ Don't miss out on this opportunity to elevate your research and take advantage of this limited-time offer: https://lnkd.in/eUxmh8Qu #DIVERSA #mRNADelivery #Nanoparticles #SpecialOffer #LifeSciences [WeAreTebubio]

🌞 Embracing August: It's Vacation Time! 🌞 August has arrived, and with its wonderful weather, DIVERSA is also going on vacation 🏖️ At DIVERSA, we believe that rest is very important, specially after a period of intense work. Thank you for being a part of our journey so far. We look forward to continuing to grow and succeed together in the months ahead. From August 1st to 18th, our facilities will be closed. But we will be active on our social media 📱 Don't miss out on the exciting news to come! ☀️ DIVERSA TECHNOLOGIES team wishes you a fantastic summer 🌴 #vacation #mentalhealth #rest #summer2024